The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
23ANDME HOLDING CO | CLASS A COM | 90138Q108 | 10,217 | 2,667,736 | SH | SOLE | 2,667,736 | 0 | 0 | ||
NEUROPACE INC | COM | 641288105 | 3,126 | 380,705 | SH | SOLE | 380,705 | 0 | 0 | ||
SINGULAR GENOMICS SYSTEMS INC | COM | 82933R100 | 14,008 | 2,219,951 | SH | SOLE | 2,219,951 | 0 | 0 |